MedPath

Thish study will Compare the Efficacy of spinal anesthesia by Intrathecal Bupivacaine 0.5% versus Intrathecal 0.75% Ropivacaine in patients undergoing Lower Abdominal and Lower Limb Surgeries

Recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2022/09/045414
Lead Sponsor
Dr Rochana Bakhshi
Brief Summary

This prospective randomised studywill be conducted in Dr D.Y.Patil hospital & medical college , Navi Mumbai,Department of Anesthesiology, after institutional ethics committee clearance.

The study population will berandomly divided into two groups.

Group 1(SR) ,n=45: will receive3.2ml of 0.75% Ropivacaine heavy

Group 2(SB), n=45: will receive3.2ml of 0.5% Bupivacaine heavy

The patients will be subjected to apreoperative anesthesia check.

Written informed consent willbe obtained before starting any study procedures.

Proper fasting guidelines will beexplained a day prior to surgery.

On the day of surgery Afterchecking the patient’s written informed consent and adequate NBM status, thepatient will be wheeled in operation theatre. The baseline preoperativeparameters would be recorded before inducing anaesthesia. ,intravenous cannula20gauge(G) or 18 gauge will be inserted on the upper extremity.Intravenous  fluid ,ringer lactate will be started.

Routine  IntraoperativeMonitoring such as

pulse oximeter (SpO2),

electrocardiogram (ECG),

non -invasive blood pressure(NIBP) will be done

Hypotension (20% decrease in MAP),if any, will be treated with intermittent boluses of intravenous ephedrine (6mg)

Bradycardia (HR < 50/ minute)will be treated with intravenous atropine 0.6 milligram (mg) or Glycopyrrolate0.2mg.

Patients will receive spinalanesthesia in sitting position, under aseptic precautions with 25G, Quincketip, spinal needle, by a qualified anesthesiologist.

Group 1 will receive intrathecal3.2 ml of 0.75% Ropivacaine and group 2 will receive intrathecal 3.2ml of 0.5% Bupivacaine.

Patients will be positioned supineimmediately.

Sensory block and level will bechecked using a 25 G hypodermic needle.

Heart rate (HR), systolic (SBP) , diastolic(DBP)and mean arterial pressure (MAP) will be measured every 2 mins from theonset of block for the first 20 mins, thereafter every 10 minutes till the endof the procedure.

**Onset of motor block**will be defined as time frominjection till motor paralysis equivalent to Bromage score 3.

**Duration of sensory block**will be defined as thetime between onset of sensory block to return of touch sensation at L1.

**Duration of motor block**will be defined as thetime between onset of motor block to complete return of motor power (Bromage 0).

**Duration of analgesia** will be defined as the timefrom commencement of block to time when patient first demand rescue analgesia(VAS > 4).

**Pain assessment** will be done by using visual analogue scale

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
90
Inclusion Criteria

Patients undergoing lower limb and lower abdominal surgeries 2.

Exclusion Criteria
  • ASA III & IV 2.
  • Patients not consenting for spinal anesthesia 3.
  • Spine abnormalities in the patient 4.
  • Coagulation disorders 5.
  • Patients with recent history of raised intracranial pressure.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Onset and duration of motor and sensory blockImmediate (Every two minutes for 20 minutes after administration)
Secondary Outcome Measures
NameTimeMethod
Hemodynamic parameters (SBP, DBP, MAP, HR)Immediate (Every two minutes for 20 minutes after administration)
Adverse eventsFrom time of administration till wearing off of spinal anesthesia

Trial Locations

Locations (1)

D Y Patil Medical College and Hospital

🇮🇳

Thane, MAHARASHTRA, India

D Y Patil Medical College and Hospital
🇮🇳Thane, MAHARASHTRA, India
Rochana Bakhshi
Principal investigator
9323272151
drrochana@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.